What if you'd held CRDF?
A $1,000 investment in Cardiff Oncology, Inc. (CRDF) at the month-end close of 2004-07 would be worth $0.55 at the close of 2026-08 — -99.9% total return, dividends reinvested. The same $1,000 in the S&P 500 would be worth $6,996.
Your scenario
Result
If you'd bought $1,000 at the start of each year
Value of $1,000 invested on January 1 of each year, held to 2026-08, dividends included.
Every year, $1,000 from 2004
| Year | Value of $1,000 | Year return |
|---|---|---|
| 2004 | $1,000 | — |
| 2005 | $460 | -54.0% |
| 2006 | $273 | -40.8% |
| 2007 | $168 | -38.5% |
| 2008 | $82.50 | -50.7% |
| 2009 | $188 | +127.3% |
| 2010 | $130 | -30.7% |
| 2011 | $138 | +5.8% |
| 2012 | $289 | +110.0% |
| 2013 | $239 | -17.2% |
| 2014 | $179 | -25.1% |
| 2015 | $225 | +25.6% |
| 2016 | $87.50 | -61.1% |
| 2017 | $12.92 | -85.2% |
| 2018 | $1.84 | -85.8% |
| 2019 | $0.72 | -61.0% |
| 2020 | $10.41 | +1350.8% |
| 2021 | $3.48 | -66.6% |
| 2022 | $0.81 | -76.7% |
| 2023 | $0.86 | +5.7% |
| 2024 | $2.51 | +193.2% |
| 2025 | $1.63 | -35.3% |
| 2026 | $0.52 | -68.0% |
Best and worst month-end to buy
The best single month-end close to have bought CRDF was 2026-07 ($0.86): $1,000 then is $1,044 today. The worst was 2004-11 ($1,728): $1,000 then is $0.52.
FAQ
What would $1,000 in CRDF be worth today?
A $1,000 investment in Cardiff Oncology, Inc. (CRDF) at the start of 2004 would be worth about $0.55 today, a total return of -99.9%. Dividends are reinvested in these figures.
What were the best and worst years for CRDF?
Cardiff Oncology, Inc. (CRDF)'s strongest calendar year since 2004 was 2020, a +1350.8% return — $1,000 held through that year became about $14,508 by year-end. Its weakest year was 2018, at -85.8%.
Does the calculator include dividends and splits?
Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.
How much would $100 per month in CRDF have grown?
Investing $100 at the end of every month since 2004-07 would have grown to about $3,894 on $26,600 invested.
Did CRDF beat the S&P 500?
Over the same period, $1,000 in the S&P 500 index would be worth $6,996. CRDF trailed the S&P 500 by +100.0% in total return.
Is this investment advice?
No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.
Methodology
Cardiff Oncology, Inc. (CRDF) historical total-return data from 2004-07 to 2026-08, reduced to month-end closes for the tables above.
Returns use adjusted close prices from Yahoo Finance historical data — adjusted for stock splits and reinvested dividends — the same convention used by major brokerages. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (Yahoo Finance): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.
Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.
What if you'd held…
Data: adjusted close prices via Yahoo Finance. As of 2026-08. Not financial advice.